# To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

> **NCT02468063** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 184 (actual)

## Conditions studied

- Cirrhosis With Septic Shock

## Interventions

- **DRUG:** Low dose terlipressin
- **DRUG:** Noradrenaline
- **DRUG:** Noradrenaline

## Key facts

- **NCT ID:** NCT02468063
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-05-31
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468063, "To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02468063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*